These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10321751)

  • 21. Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs.
    Taha AS; Dahill S; Nakshabendi I; Lee FD; Sturrock RD; Russell RI
    J Clin Pathol; 1994 Aug; 47(8):705-8. PubMed ID: 7962620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandins, NSAIDs, and cytoprotection.
    Wallace JL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):631-41. PubMed ID: 1516961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of prostaglandins in gastroduodenal mucosal protection.
    Wilson DE
    J Clin Gastroenterol; 1991; 13 Suppl 1():S65-71. PubMed ID: 1940199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?
    Wallace JL
    Physiol Rev; 2008 Oct; 88(4):1547-65. PubMed ID: 18923189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Historical overview of NSAIDs.
    Wright V
    Eur J Rheumatol Inflamm; 1993; 13(1):4-6. PubMed ID: 7821338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
    Tsibouris P; Hendrickse MT; Isaacs PE
    Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoprotection with misoprostol: use in the treatment and prevention of ulcers.
    Ballinger A
    Dig Dis; 1994; 12(1):37-45. PubMed ID: 8200123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal effects of nonsteroidal anti-inflammatory therapy.
    Raskin JB
    Am J Med; 1999 May; 106(5B):3S-12S. PubMed ID: 10390123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
    Lee TK; Stupans I
    J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-steroidal anti-inflammatory drugs: how do they damage the gut?
    Levi S; Shaw-Smith C
    Br J Rheumatol; 1994 Jul; 33(7):605-12. PubMed ID: 8019787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention and treatment of NSAIDs-induced gastrointestinal complications by prostaglandin derivatives].
    Suzuki Y; Saito E; Wakabayashi T; Suwa A
    Nihon Rinsho; 2007 Oct; 65(10):1843-9. PubMed ID: 17926534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
    Meyer-Kirchrath J; Schrör K
    Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current problems with non-specific COX inhibitors.
    McGettigan P; Henry D
    Curr Pharm Des; 2000 Nov; 6(17):1693-724. PubMed ID: 11102559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
    Wallace JL
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is NSAIDs-related gastrointestinal damage preventable?
    Gargallo CJ; Lanas A
    J Dig Dis; 2013 Feb; 14(2):55-61. PubMed ID: 23216831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.